{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:22:04Z","timestamp":1791472924389,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41391-025-01060-w","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:53:26Z","timestamp":1765544006000},"page":"488-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Artificial Intelligence (AI)-based tools in the diagnosis and management of prostate cancer: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4277-8251","authenticated-orcid":false,"given":"Hein Minn","family":"Tun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Naing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owais Ahmed","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanif Abdul","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"1060_CR1","unstructured":"WHO \u201cCancer.\u201d Accessed 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"1060_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer Statistics, 2023. CA: A Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA: A Cancer J Clin"},{"key":"1060_CR3","unstructured":"Cancer (IARC), The International Agency for Research on Cancer. \u201cGlobal Cancer Observatory.\u201d Accessed 2025. https:\/\/gco.iarc.fr\/."},{"key":"1060_CR4","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","volume":"317","author":"MS Litwin","year":"2017","unstructured":"Litwin MS, Tan H-J. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017;317:2532\u201342. https:\/\/doi.org\/10.1001\/jama.2017.7248.","journal-title":"JAMA"},{"key":"1060_CR5","unstructured":"National Cancer Institute - \u201cProstate-Specific Antigen (PSA) Test - NCI.\u201d cgvArticle, 2024. Nciglobal,ncienterprise. https:\/\/www.cancer.gov\/types\/prostate\/psa-fact-sheet."},{"key":"1060_CR6","doi-asserted-by":"publisher","unstructured":"Rl Grubb, et al. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Update on Findings from the Initial Four Rounds of Screening in a Randomized Trial. BJU International 102, (2008). https:\/\/doi.org\/10.1111\/j.1464-410X.2008.08214.x.","DOI":"10.1111\/j.1464-410X.2008.08214.x"},{"key":"1060_CR7","unstructured":"American Cancer Society, \u201cProstate Cancer Stages | Staging of Prostate Cancer.\u201d Accessed 2025. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/detection-diagnosis-staging\/staging.html."},{"key":"1060_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","volume":"22","author":"EM Schaeffer","year":"2024","unstructured":"Schaeffer EM, Srinivas S, Adra N, An Y, Bitting R, Chapin B, et al. NCCN Guidelines\u00ae Insights: Prostate Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines. J Natl Compr Cancer Netw. 2024;22:140\u201350. https:\/\/doi.org\/10.6004\/jnccn.2024.0019.","journal-title":"J Natl Compr Cancer Netw"},{"key":"1060_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic Accuracy of Multi-Parametric MRI and TRUS Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory Study. Lancet. 2017;389:815\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(16)32401-1.","journal-title":"Lancet"},{"key":"1060_CR10","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.3390\/diagnostics12112594","volume":"12","author":"AD Combes","year":"2022","unstructured":"Combes AD, Palma CA, Calopedos R, Wen L, Woo H, Fulham M, Leslie S. PSMA PET-CT in the diagnosis and staging of prostate cancer. Diagnostics. 2022;12:2594 https:\/\/doi.org\/10.3390\/diagnostics12112594.","journal-title":"Diagnostics"},{"key":"1060_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG. Prostate Cancer. Lancet. 2021;398:1075\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(21)00950-8.","journal-title":"Lancet"},{"key":"1060_CR12","doi-asserted-by":"publisher","first-page":"14257","DOI":"10.3390\/ijms232214257","volume":"23","author":"S Wasim","year":"2022","unstructured":"Wasim S, Lee SY, Kim J. Complexities of Prostate Cancer. Int J Mol Sci. 2022;23:14257 https:\/\/doi.org\/10.3390\/ijms232214257.","journal-title":"Int J Mol Sci"},{"key":"1060_CR13","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Prostate Cancer, Version 2.2025 [cited 2025]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf"},{"key":"1060_CR14","unstructured":"Ameircan Cancer Society, \u201cProstate Cancer Treatment | Surgery, Radiation, & Chemotherapy.\u201d Accessed 2025. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/treating.html."},{"key":"1060_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh R, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer\u20142024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2024;86:148\u201363. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027.","journal-title":"Eur Urol"},{"key":"1060_CR16","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1002\/pros.24354","volume":"82","author":"K Mizuno","year":"2022","unstructured":"Mizuno K, Beltran H. Future directions for precision oncology in prostate cancer. Prostate. 2022;82:S86\u201396. https:\/\/doi.org\/10.1002\/pros.24354.","journal-title":"Prostate"},{"key":"1060_CR17","unstructured":"G Kathryn. \u201cNot Your Father\u2019s Prostate Cancer.\u201d Prostate Cancer Foundation, 2016. https:\/\/www.pcf.org\/c\/not-your-fathers-prostate-cancer\/."},{"key":"1060_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ. High-Performance Medicine: The Convergence of Human and Artificial Intelligence. Nat Med. 2019;25:44\u201356. https:\/\/doi.org\/10.1038\/s41591-018-0300-7.","journal-title":"Nat Med"},{"key":"1060_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-025-01471-y","volume":"8","author":"E Fountzilas","year":"2025","unstructured":"Fountzilas E, Pearce T, Baysal MA, Chakraborty A, Tsimberidou AM. Convergence of evolving artificial intelligence and machine learning techniques in precision oncology. Npj Digit Med. 2025;8:1\u201319. https:\/\/doi.org\/10.1038\/s41746-025-01471-y.","journal-title":"Npj Digit Med"},{"key":"1060_CR20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.18632\/oncotarget.28639","volume":"15","author":"J McGale","year":"2024","unstructured":"McGale J, Liao MJ, Lopci E, Marabelle A, Dercle L. Artificial intelligence: a transformative tool in precision oncology. Oncotarget. 2024;15:588\u201389. https:\/\/doi.org\/10.18632\/oncotarget.28639.","journal-title":"Oncotarget"},{"key":"1060_CR21","unstructured":"Cochrane Handbook, Cochrane-Campbell Handbook for Qualitative Evidence Synthesis. Accessed 2024. https:\/\/training.cochrane.org\/cochrane-campbell-handbook-qualitative-evidence-synthesis."},{"key":"1060_CR22","unstructured":"PRISMA statement. PRISMA 2020 Checklist. Accessed, 2024. https:\/\/www.prisma-statement.org\/prisma-2020-checklist."},{"key":"1060_CR23","unstructured":"International prospective register of systematic reviews, \u201cPROSPERO.\u201d Accessed 2025. https:\/\/www.crd.york.ac.uk\/PROSPERO\/register\/TemplateKeywords."},{"key":"1060_CR24","unstructured":"S Guido. \u201cMeta: General Package for Meta-Analysis, 2025. https:\/\/cran.r-project.org\/web\/packages\/meta\/index.html."},{"key":"1060_CR25","unstructured":"Covidence. \u201cData Extraction for Intervention Systematic Reviews.\u201d Accessed 2024. https:\/\/www.covidence.org\/resource\/data-extraction-for-intervention-systematic-reviews\/."},{"key":"1060_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a Receiver Operating Characteristic (ROC) Curve. Radiology. 1982;143:29\u201336. https:\/\/doi.org\/10.1148\/radiology.143.1.7063747.","journal-title":"Radiology"},{"key":"1060_CR27","doi-asserted-by":"publisher","unstructured":"Egger M, et al. \u201cBias in Meta-Analysis Detected by a Simple, Graphical Test,\u201d 1997. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","DOI":"10.1136\/bmj.315.7109.629"},{"key":"1060_CR28","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/s41591-021-01517-0","volume":"27","author":"V Sounderajah","year":"2021","unstructured":"Sounderajah V, Ashrafian H, Rose S, Shah NH, Ghassemi M, Golub R, et al. A quality assessment tool for artificial intelligence-centered diagnostic test accuracy studies: QUADAS-AI. Nat Med. 2021;27:1663\u201365. https:\/\/doi.org\/10.1038\/s41591-021-01517-0.","journal-title":"Nat Med"},{"key":"1060_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2024.100694","volume":"33","author":"ML Konrad","year":"2025","unstructured":"Konrad ML, Brink C, Bertelsen AS, Lorenzen EL, Celik B, Nyborg CJ, et al. Feasibility and time gain of implementing artificial intelligence-based delineation tools in daily magnetic resonance image-guided adaptive prostate cancer radiotherapy. Phys Imaging Radiat Oncol. 2025;33:100694. https:\/\/doi.org\/10.1016\/j.phro.2024.100694.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"1060_CR30","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.euf.2021.11.009","volume":"8","author":"M Perera","year":"2022","unstructured":"Perera M, Smith L, Thompson I, Breemer G, Papa N, Patel MI, et al. Advancing traditional prostate-specific antigen kinetics in the detection of prostate cancer: a machine learning model. Eur Urol Focus. 2022;8:1204\u201310. https:\/\/doi.org\/10.1016\/j.euf.2021.11.009.","journal-title":"Eur Urol Focus"},{"key":"1060_CR31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/RLI.0000000000001102","volume":"59","author":"C Roest","year":"2024","unstructured":"Roest C, Yakar D, Rener Sitar DI, Bosma JS, Rouw DB, Fransen SJ, et al. Multimodal AI combining clinical and imaging inputs improves prostate cancer detection. Investig Radio. 2024;59:854\u201360. https:\/\/doi.org\/10.1097\/RLI.0000000000001102.","journal-title":"Investig Radio"},{"key":"1060_CR32","doi-asserted-by":"publisher","unstructured":"Zhang M, et al. Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer. Front Endocrinol 14 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1137322.","DOI":"10.3389\/fendo.2023.1137322"},{"key":"1060_CR33","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.240078","volume":"7","author":"C Roest","year":"2025","unstructured":"Roest C, Kwee TC, de Jong IJ, Schoots IG, van Leeuwen P, Heijmink S, et al. Development and validation of a deep learning model based on MRI and clinical characteristics to predict risk of prostate cancer progression. Radiology: Imaging Cancer. 2025;7:e240078. https:\/\/doi.org\/10.1148\/rycan.240078.","journal-title":"Radiology: Imaging Cancer"},{"key":"1060_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.urology.2024.11.001","volume":"196","author":"F Vasconcelos Ordones","year":"2025","unstructured":"Vasconcelos Ordones F, Kawano PR, Vermeulen L, Hooshyari A, Scholtz D, Gilling PJ, et al. A novel machine learning-based predictive model of clinically significant prostate cancer and online risk calculator. Urology. 2025;196:20\u201326. https:\/\/doi.org\/10.1016\/j.urology.2024.11.001.","journal-title":"Urology"},{"key":"1060_CR35","doi-asserted-by":"publisher","unstructured":"Yang H, Wei C, Zhou S, Mao F. Machine learning-based identification of high-risk bone metastasis factors after radical prostatectomy in prostate cancer. Front Oncol 15 (2025). https:\/\/doi.org\/10.3389\/fonc.2025.1549851.","DOI":"10.3389\/fonc.2025.1549851"},{"key":"1060_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpdig.2025.100198","volume":"3","author":"Y Hao","year":"2025","unstructured":"Hao Y, Holmes J, Hobson J, Bennett A, McKone EL, Ebner DK, et al. Retrospective comparative analysis of prostate cancer in-basket messages: responses from closed-domain large language models versus clinical teams. Mayo Clin Proc: Digital Health. 2025;3:100198. https:\/\/doi.org\/10.1016\/j.mcpdig.2025.100198.","journal-title":"Mayo Clin Proc: Digital Health"},{"key":"1060_CR37","doi-asserted-by":"publisher","unstructured":"Wang K, et al. Evaluating the feasibility of AI-predicted bpMRI image features for predicting prostate cancer aggressiveness: a multi-center study. Insights into Imaging 16,(2025): 20. https:\/\/doi.org\/10.1186\/s13244-024-01865-8.","DOI":"10.1186\/s13244-024-01865-8"},{"key":"1060_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.109339","volume":"184","author":"FE \u00d6\u011f\u00fclm\u00fc\u015f","year":"2025","unstructured":"\u00d6\u011f\u00fclm\u00fc\u015f FE, Almal\u0131o\u011flu Y, Tamam M\u00d6, Y\u0131ld\u0131r\u0131m B, Uysal E, Numano\u011flu \u00c7, et al. Integrating PET\/CT, radiomics and clinical data: an advanced multi-modal approach for lymph node metastasis prediction in prostate cancer. Comput Biol Med. 2025;184:109339. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.109339.","journal-title":"Comput Biol Med"},{"key":"1060_CR39","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.3390\/cancers15133416","volume":"15","author":"HW Lee","year":"2023","unstructured":"Lee HW, Kim E, Na I, Kim CK, Seo SI, Park H. Novel multiparametric magnetic resonance imaging-based deep learning and clinical parameter integration for the prediction of long-term biochemical recurrence-free survival in prostate cancer after radical Prostatectomy. Cancers. 2023;15:3416 https:\/\/doi.org\/10.3390\/cancers15133416.","journal-title":"Cancers"},{"key":"1060_CR40","doi-asserted-by":"publisher","first-page":"7322","DOI":"10.3390\/jcm12237322","volume":"12","author":"LM Huynh","year":"2023","unstructured":"Huynh LM, Bonebrake B, Tran J, Marasco JT, Ahlering TE, Wang S, et al. Multi-Institutional Development and Validation of a Radiomic Model to Predict Prostate Cancer Recurrence Following Radical Prostatectomy. J Clin Med. 2023;12:7322 https:\/\/doi.org\/10.3390\/jcm12237322.","journal-title":"J Clin Med"},{"key":"1060_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2024.108522","volume":"259","author":"S Saikali","year":"2025","unstructured":"Saikali S, Reddy S, Gokaraju M, Goldsztein N, Dyer A, Gamal A, et al. Development and assessment of an AI-based machine learning model for predicting urinary continence and erectile function recovery after robotic-assisted radical prostatectomy: insights from a prostate cancer referral center. Comput Methods Prog Biomed. 2025;259:108522. https:\/\/doi.org\/10.1016\/j.cmpb.2024.108522.","journal-title":"Comput Methods Prog Biomed"},{"key":"1060_CR42","doi-asserted-by":"crossref","unstructured":"Hu J, et al. \u201cAn Online Clustering Algorithm Predicting Model for Prostate Cancer Based on PHI-Related Variables and PI-RADS in Different PSA Populations. Cancer Cell International | Full Text.\u201d Accessed 2025. https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03677-2.","DOI":"10.1186\/s12935-025-03677-2"},{"key":"1060_CR43","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/bju.16456","volume":"134","author":"I Arvidsson","year":"2024","unstructured":"Arvidsson I, Svanemur E, Marginean F, Simoulis A, Overgaard NC, \u00c5str\u00f6m K, et al. Artificial intelligence for detection of prostate cancer in biopsies during active surveillance. BJU Int. 2024;134:1001\u20139. https:\/\/doi.org\/10.1111\/bju.16456.","journal-title":"BJU Int"},{"key":"1060_CR44","doi-asserted-by":"publisher","unstructured":"Yuan LH, Huang SW, Chou D, Tsai CY. The in-depth comparative analysis of four large language ai models for risk assessment and information retrieval from multi-modality prostate cancer work-up reports. World J Men\u2019s Health 42 (2024). https:\/\/doi.org\/10.5534\/wjmh.240173.","DOI":"10.5534\/wjmh.240173"},{"key":"1060_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00659-w","volume":"5","author":"C Lee","year":"2022","unstructured":"Lee C, Light A, Saveliev ES, van der Schaar M, Gnanapragasam VJ. Developing machine learning algorithms for dynamic estimation of progression during active surveillance for prostate cancer. Npj Digit Med. 2022;5:110. https:\/\/doi.org\/10.1038\/s41746-022-00659-w.","journal-title":"Npj Digit Med"},{"key":"1060_CR46","doi-asserted-by":"publisher","unstructured":"Yang L, et al. Radiomic machine learning and external validation based on 3.0 T mpMRI for prediction of intraductal carcinoma of prostate with different proportion. Front Oncol 12 (2022). https:\/\/doi.org\/10.3389\/fonc.2022.934291.","DOI":"10.3389\/fonc.2022.934291"},{"key":"1060_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2024.100641","volume":"32","author":"C Church","year":"2024","unstructured":"Church C, Yap M, Bessrour M, Lamey M, Granville D. Automated plan generation for prostate radiotherapy patients using deep learning and scripted optimization. Phys Imaging Radiat Oncol. 2024;32:100641. https:\/\/doi.org\/10.1016\/j.phro.2024.100641.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"1060_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251326021","volume":"11","author":"L Korolkov","year":"2025","unstructured":"Korolkov L, Robinson HA, Mouratis K. Development of a digital treatment analyzer for the management of prostate cancer patients, with the help of real world data and use of predictive modelling. Digital Health. 2025;11:20552076251326021. https:\/\/doi.org\/10.1177\/20552076251326021.","journal-title":"Digital Health"},{"key":"1060_CR49","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.euf.2020.11.001","volume":"7","author":"F Marginean","year":"2021","unstructured":"Marginean F, Arvidsson I, Simoulis A, Christian Overgaard N, \u00c5str\u00f6m K, Heyden A, et al. An artificial intelligence\u2013based support tool for automation and standardisation of gleason grading in prostate biopsies. Eur Urol Focus. 2021;7:995\u20131001. https:\/\/doi.org\/10.1016\/j.euf.2020.11.001.","journal-title":"Eur Urol Focus"},{"key":"1060_CR50","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(19)30037-6","volume":"393","author":"GS Collins","year":"2019","unstructured":"Collins GS, Moons KGM. Reporting of artificial intelligence prediction models. Lancet (Lond, Engl). 2019;393:1577\u201379. https:\/\/doi.org\/10.1016\/S0140-6736(19)30037-6.","journal-title":"Lancet (Lond, Engl)"},{"key":"1060_CR51","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","volume":"18","author":"A Hosny","year":"2018","unstructured":"Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18:500\u201310. https:\/\/doi.org\/10.1038\/s41568-018-0016-5.","journal-title":"Nat Rev Cancer"},{"key":"1060_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0681-4","volume":"19","author":"JAM Sidey-Gibbons","year":"2019","unstructured":"Sidey-Gibbons JAM, Sidey-Gibbons CJ. Machine learning in medicine: a practical introduction. BMC Med Res Methodol. 2019;19:64. https:\/\/doi.org\/10.1186\/s12874-019-0681-4.","journal-title":"BMC Med Res Methodol"},{"key":"1060_CR53","doi-asserted-by":"publisher","unstructured":"Collin H, Keogh K, Basto M, Loeb S, & Roberts MJ. ChatGPT can help guide and empower patients after prostate cancer diagnosis. prostate cancer and prostatic diseases 28,(2025). https:\/\/doi.org\/10.1038\/s41391-024-00864-6.","DOI":"10.1038\/s41391-024-00864-6"},{"key":"1060_CR54","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41391-024-00826-y","volume":"28","author":"JS Hershenhouse","year":"2025","unstructured":"Hershenhouse JS, Mokhtar D, Eppler MB, Rodler S, Storino Ramacciotti L, Ganjavi C, et al. Accuracy, readability, and understandability of large language models for prostate cancer information to the public. Prostate Cancer Prostat Dis. 2025;28:394\u201399. https:\/\/doi.org\/10.1038\/s41391-024-00826-y.","journal-title":"Prostate Cancer Prostat Dis"},{"key":"1060_CR55","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41391-024-00789-0","volume":"28","author":"R Lombardo","year":"2025","unstructured":"Lombardo R, Gallo G, Stira J, Turchi B, Santoro G, Riolo S, et al. Quality of Information and appropriateness of open AI outputs for prostate cancer. Prostate Cancer Prostat Dis. 2025;28:229\u201331. https:\/\/doi.org\/10.1038\/s41391-024-00789-0.","journal-title":"Prostate Cancer Prostat Dis"},{"key":"1060_CR56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41391-023-00750-7","volume":"27","author":"R Lombardo","year":"2024","unstructured":"Lombardo R, Cicione A, Santoro G, De Nunzio C. ChatGPT in prostate cancer: myth or reality?. Prostate Cancer Prostat Dis. 2024;27:9\u201310. https:\/\/doi.org\/10.1038\/s41391-023-00750-7.","journal-title":"Prostate Cancer Prostat Dis"},{"key":"1060_CR57","doi-asserted-by":"publisher","unstructured":"Ayyad SM, NB Abdel-Hamid, HA Ali, and LM Labib. Multimodality imaging in prostate cancer diagnosis using artificial intelligence: basic concepts and current state-of-the-art. Multimed Tools Appl, 2025. https:\/\/doi.org\/10.1007\/s11042-025-20786-2.","DOI":"10.1007\/s11042-025-20786-2"},{"key":"1060_CR58","doi-asserted-by":"publisher","unstructured":"Adleman J, et al. Evaluating the prognostic significance of artificial intelligence-delineated gross tumor volume and prostate volume measurements for prostate radiotherapy. Radiother Oncol 207 (2025): 110866. https:\/\/doi.org\/10.1016\/j.radonc.2025.110866.","DOI":"10.1016\/j.radonc.2025.110866"},{"key":"1060_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13628-9","volume":"25","author":"L Cao","year":"2025","unstructured":"Cao L, He R, Zhang A, Li L, Cao W, Liu N, et al. Development of a deep learning system for predicting biochemical recurrence in prostate cancer. BMC Cancer. 2025;25:232. https:\/\/doi.org\/10.1186\/s12885-025-13628-9.","journal-title":"BMC Cancer"},{"key":"1060_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.112063","volume":"186","author":"W Zhu","year":"2025","unstructured":"Zhu W, Tang Y, Qi L, Gao X, Hu S, Chen MF, et al. Machine learning models for enhanced diagnosis and risk assessment of prostate cancer with 68Ga-PSMA-617 PET\/CT. Eur J Radio. 2025;186:112063. https:\/\/doi.org\/10.1016\/j.ejrad.2025.112063.","journal-title":"Eur J Radio"},{"key":"1060_CR61","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13244-024-01783-9","volume":"15","author":"E Mylona","year":"2024","unstructured":"Mylona E, Zaridis DI, Kalantzopoulos C\u039d, Tachos NS, Regge D, Papanikolaou N, et al. Optimizing radiomics for prostate cancer diagnosis: feature selection strategies, machine learning classifiers, and MRI sequences. Insights Into Imaging. 2024;15:265 https:\/\/doi.org\/10.1186\/s13244-024-01783-9.","journal-title":"Insights Into Imaging"},{"key":"1060_CR62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13244-024-01682-z","volume":"15","author":"J Liang","year":"2024","unstructured":"Liang J, Yu Z, Gao F, Li M. T2-weighted imaging-based deep-learning method for noninvasive prostate cancer detection and gleason grade prediction: a multicenter study. Insights Into Imaging. 2024;15:111 https:\/\/doi.org\/10.1186\/s13244-024-01682-z.","journal-title":"Insights Into Imaging"},{"key":"1060_CR63","doi-asserted-by":"publisher","DOI":"10.1177\/03000605241275338","volume":"52","author":"ZL Chen","year":"2024","unstructured":"Chen ZL, Huang ZC, Lin SS, Li ZH, Dou RL, Xu Y, et al. Clinical value of a radiomics model based on machine learning for the prediction of prostate cancer. J Int Med Res. 2024;52:03000605241275338. https:\/\/doi.org\/10.1177\/03000605241275338.","journal-title":"J Int Med Res"},{"key":"1060_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13203-8","volume":"24","author":"K Sato","year":"2024","unstructured":"Sato K, Sakamoto S, Saito S, Shibata H, Yamada Y, Takeuchi N, et al. Time-dependent personalized prognostic analysis by machine learning in biochemical recurrence after radical prostatectomy: a retrospective cohort study. BMC Cancer. 2024;24:1446. https:\/\/doi.org\/10.1186\/s12885-024-13203-8.","journal-title":"BMC Cancer"},{"key":"1060_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-024-00667-x","volume":"24","author":"C Hu","year":"2024","unstructured":"Hu C, Qiao X, Hu C, Cao C, Wang X, Bao J. The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical Prostatectomy. Cancer Imaging. 2024;24:23. https:\/\/doi.org\/10.1186\/s40644-024-00667-x.","journal-title":"Cancer Imaging"},{"key":"1060_CR66","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4103\/iju.iju_75_24","volume":"40","author":"G Singh","year":"2024","unstructured":"Singh G, Agrawal M, Talwar G, Kankaria S, Sharma G, Ahluwalia P, et al. Artificial intelligence in prostate cancer: the potential of machine learning models and neural networks to predict biochemical recurrence after robot-assisted radical Prostatectomy. Indian J Urol. 2024;40:260\u20135. https:\/\/doi.org\/10.4103\/iju.iju_75_24.","journal-title":"Indian J Urol"},{"key":"1060_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100247","volume":"36","author":"E Erak","year":"2023","unstructured":"Erak E, Oliveira LD, Mendes AA, Dairo O, Ertunc O, Kulac I, et al. Predicting prostate cancer molecular subtype with deep learning on histopathologic images. Mod Pathol. 2023;36:100247. https:\/\/doi.org\/10.1016\/j.modpat.2023.100247.","journal-title":"Mod Pathol"},{"key":"1060_CR68","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S2589-7500(23)00067-5","volume":"5","author":"JCC Kwong","year":"2023","unstructured":"Kwong JCC, Khondker A, Meng E, Taylor N, Kuk C, Perlis N, et al. Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based side-specific extra-prostatic extension risk assessment tool (SEPERA) for patients undergoing Radical Prostatectomy: A retrospective cohort study. Lancet Digit Health. 2023;5:e435\u201345. https:\/\/doi.org\/10.1016\/S2589-7500(23)00067-5.","journal-title":"Lancet Digit Health"},{"key":"1060_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106340","volume":"152","author":"J Xiang","year":"2023","unstructured":"Xiang J, Wang X, Wang X, Zhang J, Yang S, Yang W, et al. Automatic diagnosis and grading of prostate cancer with weakly supervised learning on whole slide images. Comput Biol Med. 2023;152:106340. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106340.","journal-title":"Comput Biol Med"},{"key":"1060_CR70","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222276","volume":"307","author":"CA Hamm","year":"2023","unstructured":"Hamm CA, et al. Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI. Radiology. 2023;307:e222276. https:\/\/doi.org\/10.1148\/radiol.222276.","journal-title":"Radiology"},{"key":"1060_CR71","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1007\/s00330-023-09438-x","volume":"33","author":"N Sushentsev","year":"2023","unstructured":"Sushentsev N, Rundo L, Abrego L, Li Z, Nazarenko T, Warren AY, et al. Time Series Radiomics for the Prediction of Prostate Cancer Progression in Patients on Active Surveillance. Eur Radio. 2023;33:3792\u20133800. https:\/\/doi.org\/10.1007\/s00330-023-09438-x.","journal-title":"Eur Radio"},{"key":"1060_CR72","doi-asserted-by":"publisher","first-page":"161.e1","DOI":"10.1016\/j.urolonc.2021.08.007","volume":"40","author":"M Nayan","year":"2022","unstructured":"Nayan M, Salari K, Bozzo A, Ganglberger W, Lu G, Carvalho F, et al. A machine learning approach to predict progression on active surveillance for prostate cancer. Urolc Oncol: Semin Orig Investig. 2022;40:161.e1\u2013161.e7. https:\/\/doi.org\/10.1016\/j.urolonc.2021.08.007.","journal-title":"Urolc Oncol: Semin Orig Investig"},{"key":"1060_CR73","doi-asserted-by":"publisher","unstructured":"Sargos et al. Deep neural networks outperform the CAPRA score in predicting biochemical recurrence after prostatectomy. Front Oncol 10 (2021). https:\/\/doi.org\/10.3389\/fonc.2020.607923.","DOI":"10.3389\/fonc.2020.607923"},{"key":"1060_CR74","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.3390\/cancers13123098","volume":"13","author":"Y Yan","year":"2021","unstructured":"Yan Y, Shao L, Liu Z, He W, Yang G, Liu J, et al. Deep learning with quantitative features of magnetic resonance images to predict biochemical recurrence of radical prostatectomy: a multi-center study. Cancers. 2021;13:3098 https:\/\/doi.org\/10.3390\/cancers13123098.","journal-title":"Cancers"},{"key":"1060_CR75","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/bju.15386","volume":"128","author":"F Wessels","year":"2021","unstructured":"Wessels F, Schmitt M, Krieghoff-Henning E, Jutzi T, Worst TS, Waldbillig F, et al. Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancer. BJU Int. 2021;128:352\u201360. https:\/\/doi.org\/10.1111\/bju.15386.","journal-title":"BJU Int"},{"key":"1060_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-021-00849-w","volume":"21","author":"S Yu","year":"2021","unstructured":"Yu S, Tao J, Dong B, Fan Y, Du H, Deng H, et al. Development and head-to-head comparison of machine-learning models to identify patients requiring prostate biopsy. BMC Urol. 2021;21:80. https:\/\/doi.org\/10.1186\/s12894-021-00849-w.","journal-title":"BMC Urol"},{"key":"1060_CR77","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/a14050147","volume":"14","author":"FD Beacher","year":"2021","unstructured":"Beacher FD, Mujica-Parodi LR, Gupta S, Ancora LA. Machine learning predicts outcomes of Phase III clinical trials for prostate cancer. Algorithms. 2021;14:147 https:\/\/doi.org\/10.3390\/a14050147.","journal-title":"Algorithms"},{"key":"1060_CR78","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1470-2045(19)30739-9","volume":"21","author":"W Bulten","year":"2020","unstructured":"Bulten W, Pinckaers H, van Boven H, Vink R, de Bel T, van Ginneken B, et al. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. Lancet Oncol. 2020;21:233\u201341. https:\/\/doi.org\/10.1016\/S1470-2045(19)30739-9.","journal-title":"Lancet Oncol"},{"issue":"Apr","key":"1060_CR79","doi-asserted-by":"publisher","first-page":"80823","DOI":"10.21037\/qims.2020.03.08","volume":"10","author":"DJ Winkel","year":"2020","unstructured":"Winkel DJ, Breit HC, Shi B, Boll DT, Seifert HH, Wetterauer C. Predicting clinically significant prostate cancer from quantitative image features including compressed sensing radial MRI of prostate perfusion using machine learning: comparison with PI-RADS v2 assessment scores. Quant Imaging Med Surg. 2020;10(Apr):80823\u201380823. https:\/\/doi.org\/10.21037\/qims.2020.03.08.","journal-title":"Quant Imaging Med Surg"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01060-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01060-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01060-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T21:44:49Z","timestamp":1786657489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01060-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1060"],"URL":"https:\/\/doi.org\/10.1038\/s41391-025-01060-w","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The systematic review was registered in the International Prospective Register of Systematic Reviews (PROSPERO) under identification number CRD420251051871 and follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 checklist.","order":1,"name":"Ethics","label":"Registration and protocol","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}